MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$350,000
Net Income
-$85,088,000
Net Profit Margin
-24310.86%
EPS
-$0.41
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
350,000
3,000,000
6,999,000
0
Research and development expenses
76,483,000
70,563,000
55,415,000
68,262,000
Change in fair value of contingent consideration liability
-
-
-
0
General and administrative expenses
14,691,000
11,027,000
12,215,000
12,129,000
Total operating expenses
91,174,000
81,590,000
67,630,000
80,391,000
Loss from operations
-90,824,000
-78,590,000
-60,631,000
-80,391,000
Interest income
7,115,000
5,352,000
5,710,000
6,407,000
Other expense
-
53,000
-
-
Other income (expense)
2,000
-
31,000
-165,000
Total other income, net
7,117,000
5,299,000
5,741,000
6,242,000
Net loss
-83,707,000
-73,291,000
-54,890,000
-74,149,000
Unrealized holding (loss) gain
-1,381,000
-172,000
240,000
656,000
Total other comprehensive (loss) income
-1,381,000
-172,000
240,000
656,000
Total comprehensive loss
-85,088,000
-73,463,000
-54,650,000
-73,493,000
Basic EPS
-0.41
-0.41
-0.315
-0.43
Diluted EPS
-0.41
-0.41
-0.403*
-0.43
Basic Average Shares
202,849,466
179,849,137
173,459,246
172,389,209
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Total comprehensiveloss-$85,088,000 (-20.56%↓ Y/Y)Interest income$7,115,000 (0.14%↑ Y/Y)Other income(expense)$2,000 (100.32%↑ Y/Y)Net loss-$83,707,000 (-18.94%↓ Y/Y)Total othercomprehensive (loss) income-$1,381,000 (-587.06%↓ Y/Y)Total other income,net$7,117,000 (9.97%↑ Y/Y)Loss from operations-$90,824,000 (-18.19%↓ Y/Y)Unrealized holding (loss)gain-$1,381,000 (-587.06%↓ Y/Y)Total revenue$350,000 (-48.30%↓ Y/Y)Total operatingexpenses$91,174,000 (17.61%↑ Y/Y)Research and developmentexpenses$76,483,000 (19.70%↑ Y/Y)General andadministrative expenses$14,691,000 (7.81%↑ Y/Y)

Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics, Inc. (RLAY)